The content of the training

Overview of new pharmaceuticals according to the theme of the webinar
Elli Leppä, PhD, Development Pharmacist, Pharmaca Health Intelligence Oy 

New pharmaceuticals from an expert's perspective and discussion
Jukka Alinikula, PhD, Docent, Adjunct Professor of Immuno-pharmacology, Institute of Biomedicine, University of Turku 
Elli Leppä, PhD, Development Pharmacist, Pharmaca Health Intelligence Oy 

In the training we will dive into the indication for drug use, drug formulation, dosage and administration, side effects, as well as pharmacodynamics and pharmacokinetics. Additionally, we will explore the positioning of pharmaceuticals within their therapeutic groups. Furthermore, we will address other topics such as contraindications and drug interactions.

We discuss the following new active ingredients: mirikizumab, spesolimab, anifrolumab, voclosporin, and avacopan.

The expert speakers 

Jukka Alinikula
The trainer of this education, Jukka Alinikula, PhD, is an Adjunct Professor of Immuno-pharmacology and a Docent at the University of Turku. Alinikula is leading a research group while also teaching immuno-pharmacology at the Institute of Biomedicine, University of Turku. Having completed a post-doctoral period at Yale Immunobiology (United States), Alinikula has attained extensive experience in immunology research in both domestic and international roles. His research is focused on the cell and molecular biology of the development of efficient antibody-mediated immune defense.

Elli Leppä
Elli Leppä, PhD, is a Development Pharmacist with over a decade of expertise in developing medical information tools and services tailored for healthcare professionals and consumers. Her areas of specialization encompass curating pharmacological information into user-friendly and clinically effective formats. Elli earned her doctoral degree in neuropharmacology from the Faculty of Medicine at the University of Helsinki in 2011.